Exchange: NASDAQ·Updated 04:10 PM EDT
News
all
press releases
BGLC Stock Tumbled Over 13% Today: Why Is VitaGuard Commercialization Agreement Drawing Investor Attention?
The partnership aims to support the planned commercialization of minimal residual disease testing in Southeast Asia.
Stocktwits
<
1
>

Advertisement|Remove ads.